Unique ID issued by UMIN | UMIN000003901 |
---|---|
Receipt number | R000004612 |
Scientific Title | Evaluation of the required concentration of dexmedetomidine after abdominal aorta aneurysm surgery with fentanyl- or remifentanil-based anesthetic management |
Date of disclosure of the study information | 2010/07/14 |
Last modified on | 2010/07/11 23:16:32 |
Evaluation of the required concentration of dexmedetomidine after abdominal aorta aneurysm surgery with fentanyl- or remifentanil-based anesthetic management
Evaluation of the required plasma concentration of dexmedetomidine after abdominal aorta aneurysm surgery
Evaluation of the required concentration of dexmedetomidine after abdominal aorta aneurysm surgery with fentanyl- or remifentanil-based anesthetic management
Evaluation of the required plasma concentration of dexmedetomidine after abdominal aorta aneurysm surgery
Japan |
Abdominal aorta aneurysm
Intensive care medicine |
Others
NO
Since change from traditional perioperative management to a new one with a new drug is thought to make the required concentration of the sedative drug in post-operative management change, we evaluate the actual required concentration.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Plasma concentration of dexmedetomidine and outcome
Hemodynamics, respiratory condition, sedative condition
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Active
2
Treatment
Medicine |
Fentanyl is used for analgesia during surgery
Remifentanil is used for analgesia during surgery
20 | years-old | <= |
Not applicable |
Male and Female
Patient undergoing abdominal aorta aneurysm surgery with an age of 20 years or more.
Exclusion criteria were severe cardiovascular disease and concurrent systemic disorders. Patients with arrhythmias such as atrial fibrillation or disturbance in the conduction system and those receiving alpha-methyldopa or clonidine treatment were also excluded from this study.
14
1st name | |
Middle name | |
Last name | Takayuki Kunisawa |
Asahikawa Medical College
Anesthesiology and Critical Care Medicine
2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido
0166-68-2583
1st name | |
Middle name | |
Last name | Takayuki Kunisawa |
Asahikawa Medical College
Anesthesiology and Critical Care Medicine
2-1-1-1 Midorigaoka-higashi, Asahikawa, Hokkaido
0166-68-2583
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical College.
None
Self funding
NO
旭川医科大学病院(北海道)
2010 | Year | 07 | Month | 14 | Day |
Partially published
The required dexmedetomidine concentration in the remifentanil group was triple that in the fentanyl group. However, the required time to extubation was shorter and urine output was larger in the remifentanil group than those in the fentanyl group. (Presented at The 28th Annual Meeting of Japan Society for Clinical Anesthesia, Kyoto, November 22, 2008.)
Completed
2006 | Year | 07 | Month | 31 | Day |
2007 | Year | 04 | Month | 01 | Day |
2009 | Year | 04 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 08 | Month | 01 | Day |
2010 | Year | 07 | Month | 01 | Day |
2010 | Year | 07 | Month | 11 | Day |
2010 | Year | 07 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004612
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |